Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

NCT02950922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: RVT-501 0.2% ointment
DRUG: RVT-501 0.5% ointment
OTHER: Vehicle ointment

Sponsor

Dermavant Sciences GmbH